Table S1.
Relationship between RNA expression of EIF3B and clinicopathological features in GC patients using qPCR analysis
| Parameter | EIF3B expression | χ2 | Pa | |
|---|---|---|---|---|
| Low n (%) |
High n (%) |
|||
| Gender | 0.406 | 0.524 | ||
| Male | 18(48.6) | 19(51.4) | ||
| Female | 17(41.5) | 24(58.5) | ||
| Age (y) | 0.333 | 0.564 | ||
| ≤60 | 14(41.2) | 20(58.8) | ||
| >60 | 21(47.7) | 23(52.3) | ||
| Depth of invasion | 0.000 | 0.093 | ||
| T1–2 | 5(50.0) | 5(50.0) | ||
| T3–4 | 30(44.1) | 38(55.9) | ||
| Lymph node metastasis | 2.600 | 0.107 | ||
| N0 | 9(64.3) | 5(35.7) | ||
| N1 | 26(40.6) | 38(59.4) | ||
| Distant metastasis | 0.452 | 0.501 | ||
| M0 | 32(47.1) | 36(52.9) | ||
| M1 | 3(30.0) | 7(70.0) | ||
| TNM stage | 3.235 | 0.072 | ||
| Ⅰ–Ⅱ | 21(55.3) | 17(44.7) | ||
| Ⅲ–Ⅳ | 14(35.0) | 26(65.0) | ||
Note: aChi-square test.